Phase I trial of anti-CD74 (hLL1) Antibody Therapy in B-cell malignancies

Update: this study is closed to enrollment. 

Previous expericence with antibody therapy in both non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) suggests the need for further exploration of new antibody treatments for these diseases.

This is a Phase I, open-label study being conducted in patients with recurrent non-Hodgkin’s lymphoma or chronic lymphocytic leukemia who have progressed after at least one prior standard treatment.

Click here to for the clinical and research profile of John Leonard, MD, the physician leading the study.

Weill Cornell’s Dr. Ruben Niesvizky and Dr. Ellen Ritchie Raising Funds for LLS Man/Woman of the Year

Drs. Ellen Ritchie and Ruben Niesvizky are campaigning for the Leukemia and Lymphoma Society’s (LLS) Woman and Man of the Year awards. The campaign is a 10-week competition to raise at least $20,000 each in honor of four local pediatric cancer patients. The candidates who raise the most money will be awarded the titles. The money raised in this campaign provides funds for LLS education and support services for patients and their families as well as cancer research.

Please help raise funds for Ellen and Ruben between now and May 19. Click here for Dr. Ritchie’s fundraising page. Click here for Dr. Niesvizky’s fundraising page.

Treatment Research Study Available for Untreated Hodgkin Lymphoma

Pilot study of abbreviated chemotherapy based on early positron emission tomography in Hodgkin lymphoma

Update: this study is closed to enrollment. 

Patients in this study will be treated with ABVD (adriamycin, bleomycin, vinblastine and dacarbazine) on Days 1 and 15 of each cycle according to standard treatment guidelines.  The purpose of this study is to determine the progression-free survival at 36 months for patients with Hodgkin lymphoma who achieve a response after one cycle of ABVD chemotherapy.

Click here for more information on this study for people with untreated Hodgkin lymphoma or call June Greenberg, RN at (212) 746-2651.

Click here for the clinical and research profile of Rebecca Elstrom, MD, the physician leading the study at Weill Cornell Medical Center.